We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




POC Urinalysis System Evaluated for Schistosomiasis

By LabMedica International staff writers
Posted on 02 Jul 2019
Schistosoma haematobium is one of the three main human species of digenetic trematodes, belonging to a group of blood flukes, and causes the urinary form of schistosomiasis and remains a significant public health problem worldwide, despite years of efforts to control it.

Hematuria is one of the notable indirect indicators of S. More...
haematobium infection and is commonly assessed along with other routine screens using a urinary dipstick test. A portable “field friendly” electronic analyzer would offer an automated and thus more objective read-out compared to visual-read dipstick methods.

Medical scientist associated with the Swiss Tropical and Public Health Institute (Basel, Switzerland) collected urine samples as part of a Phase 2 dose-finding clinical trial with praziquantel in S. haematobium-infected children. Collectively, 174 school-aged and 170 preschool-aged children were enrolled in the trial, which took place in November 2015 in Côte d’Ivoire.

The team compared a visual-read of the urine dipstick strips Multistix PRO to the automated reader CLINITEK Status+ analyzer, also manufactured by Siemens Healthcare Diagnostics. For the leukocyte, urobilinogen, proteins, blood, ketone bodies and bilirubin parameters, findings were compared employing linear weighted Cohen’s kappa (κ) coefficient statistic. Results were then also stratified according to infection intensity using WHO standards for S. haematobium infection intensity classification: egg count of 1 to 49 eggs per 10 mL urine was regarded as light; and egg count of ≥ 50 eggs/10 mL urine was regarded as heavy infection.

The team reported that the children harbored predominantly light intensity infections (83.7% of samples) and this was true for both pre-school-aged (90.5% of samples) and school-aged children (72.4% of samples). Of the children found to have eggs in their urine, hematuria was detected in 64.3% of their samples by visual read-out and in 63.0% of their samples by machine read-out. The observed agreement between the two techniques was fair for bilirubin and ketone bodies, moderate for urobilinogen and proteins, good for leukocytes, and very good for nitrites and hematuria.

The authors concluded that the agreement between visual and automated readout of the Multistix Pro urine dipsticks was fair to moderate for most parameters. However, a very good agreement was observed for hematuria and nitrites, two parameters in detecting S. haematobium as well as urinary tract infections, which are often associated with schistosomiasis. The findings reaffirm that, although hematuria might be a good indicator of morbidity due to urinary schistosomiasis, its utility as a diagnostic tool in areas of low-intensity infections is dubious, therefore underscoring the urgent need for more sensitive point-of-care diagnostic tools. The study was published on June 13, 2019, in the journal Parasites & Vectors.

Related Links:
Swiss Tropical and Public Health Institute


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.